BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10952489)

  • 21. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Lipszyc M; Salmon I; Brotchi J; Levivier M
    J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography with 11C-methionine of intracranial tumours compared with histology of multiple biopsies.
    Mosskin M; Bergström M; Collins VP; Ehrin E; Eriksson L; von Holst H; Norén G
    Acta Radiol Suppl; 1986; 369():157-60. PubMed ID: 2980438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
    Rodriguez M
    Acta Radiol Suppl; 1998; 417():1-36. PubMed ID: 9645167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
    Stokkel M; Stevens H; Taphoorn M; Van Rijk P
    Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
    Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
    Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
    J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging.
    Ohtani T; Kurihara H; Ishiuchi S; Saito N; Oriuchi N; Inoue T; Sasaki T
    Eur J Nucl Med; 2001 Nov; 28(11):1664-70. PubMed ID: 11702108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
    No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography.
    Iwadate Y; Shinozaki N; Matsutani T; Uchino Y; Saeki N
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1016-21. PubMed ID: 26848169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma.
    Kracht LW; Friese M; Herholz K; Schroeder R; Bauer B; Jacobs A; Heiss WD
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):868-73. PubMed ID: 12692687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
    Adams S; Baum RP; Stuckensen T; Bitter K; Hör G
    Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity.
    Roodakker KR; Alhuseinalkhudhur A; Al-Jaff M; Georganaki M; Zetterling M; Berntsson SG; Danfors T; Strand R; Edqvist PH; Dimberg A; Larsson EM; Smits A
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):569-579. PubMed ID: 30109401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
    Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
    Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
    J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET scanning and the human immunodeficiency virus-positive patient.
    O'Doherty MJ; Barrington SF; Campbell M; Lowe J; Bradbeer CS
    J Nucl Med; 1997 Oct; 38(10):1575-83. PubMed ID: 9379195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using
    Takahashi M; Soma T; Mukasa A; Koyama K; Arai T; Momose T
    Ann Nucl Med; 2017 Apr; 31(3):250-259. PubMed ID: 28194701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron emission tomography in oncology.
    Leskinen-Kallio S
    Clin Physiol; 1994 May; 14(3):329-35. PubMed ID: 8026150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
    Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
    J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.